Lewis H. Titterton Jr. - 01 Jun 2021 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Issuer symbol
ANIX
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jun 2021, 17:00:34 UTC
Next filing
15 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 01 Jun 2021 Common Stock 30,000 $4.02 Direct F1, F2
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +200,000 $0.000000 200,000 01 Jun 2021 Common Stock 200,000 $4.02 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021.
F3 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.